NAVLE Nervous

Canine Fibrocartilaginous Embolism (FCE) Study Guide

Fibrocartilaginous embolism (FCE), also known as fibrocartilaginous embolic myelopathy (FCEM), is an acute, non-compressive, ischemic myelopathy caused by embolization of spinal cord vasculature with fibrocartilaginous material histologically...

Overview and Clinical Importance

Fibrocartilaginous embolism (FCE), also known as fibrocartilaginous embolic myelopathy (FCEM), is an acute, non-compressive, ischemic myelopathy caused by embolization of spinal cord vasculature with fibrocartilaginous material histologically identical to the nucleus pulposus of the intervertebral disc. This condition represents the most common cause of ischemic myelopathy in dogs and is often described as a "spinal stroke."

FCE is a high-yield topic for the NAVLE because it requires integration of neuroanatomy, clinical reasoning, and differentiation from other acute myelopathies. Understanding FCE is essential for any veterinarian, as timely recognition and appropriate supportive care significantly impact patient outcomes.

Factor Characteristics
Breed Predisposition Large and giant breed, non-chondrodystrophic dogs most commonly affected. Miniature Schnauzers and Shetland Sheepdogs are overrepresented among small breeds. Irish Wolfhounds, German Shepherds, Labrador Retrievers frequently affected.
Age Young to middle-aged adults (median 3-6 years). Range: 2 months to 13 years. Can occur in immature animals.
Sex Males may be slightly overrepresented (male to female ratio 1:1 to 2.5:1 in various studies)
Inciting Event Often occurs during vigorous exercise (running, jumping, playing). May occur following minor trauma. Sometimes no identifiable trigger.

Anatomy and Pathophysiology

Intervertebral Disc Anatomy

The intervertebral disc consists of two main components: the nucleus pulposus (central gelatinous core composed of type II collagen, proteoglycans, and 70-90% water) and the annulus fibrosus (outer fibrous ring of concentric lamellae containing type I collagen). The nucleus pulposus is the fibrocartilaginous material responsible for FCE. It is the remnant of the embryonic notochord and functions as a hydraulic cushion during axial loading.

Pathophysiology of FCE

The exact mechanism by which nucleus pulposus material enters the spinal vasculature remains incompletely understood. Several theories have been proposed:

  • Direct arterial entry: Nucleus pulposus material enters arterial vessels during acute increases in intradiscal pressure (e.g., during vigorous exercise or trauma)
  • Retrograde venous flow: Material enters the venous plexus and travels retrograde into arteriolar systems during Valsalva-like maneuvers
  • Persistence of embryonic vessels: Remnant vessels between the disc and spinal cord vasculature may allow entry of disc material

Once fibrocartilaginous material enters the spinal vasculature, it occludes small arteries and/or veins, resulting in ischemic necrosis of dependent regions of the spinal cord parenchyma. The gray matter is typically more severely affected than white matter due to higher metabolic demands.

High-YieldThe hallmark of FCE is that neurological deficits are typically NON-PROGRESSIVE after the first 12-24 hours. If deficits continue to worsen beyond 24 hours, reconsider the diagnosis and rule out compressive lesions or progressive myelomalacia.
Localization Clinical Signs Reflex Changes
C1-C5 Tetraparesis/tetraplegia. All four limbs affected. Possible respiratory compromise. UMN signs to all four limbs: normal to increased reflexes, increased tone
C6-T2 Tetraparesis/tetraplegia. Short, choppy forelimb gait. May see 'two-engine gait' - short stride forelimbs, long stride hindlimbs. LMN signs to forelimbs: decreased reflexes, decreased tone, neurogenic atrophy. UMN signs to hindlimbs.
T3-L3 Paraparesis/paraplegia. Normal forelimbs. Loss of cutaneous trunci reflex caudal to lesion. UMN signs to hindlimbs: normal to increased reflexes, increased tone. Crossed extensor reflex may be present.
L4-S3 Paraparesis/paraplegia. Urinary/fecal incontinence common. May have flaccid tail. LMN signs to hindlimbs: decreased to absent reflexes, decreased tone, early neurogenic atrophy

Signalment and Breed Predispositions

NAVLE TipThink FCE when you see: Large breed + young adult + acute onset during exercise + asymmetric neurologic deficits + NON-PAINFUL presentation. The classic scenario is a young Labrador that was playing fetch, yelped once, and now has asymmetric paralysis without spinal pain.
MRI Sequence Characteristic Findings in FCE
T2-Weighted Focal, relatively sharply demarcated INTRAMEDULLARY HYPERINTENSITY (bright signal) within spinal cord parenchyma. Often lateralized. Predominantly affects gray matter. Length is generally greater than one vertebral body.
T1-Weighted Lesion appears ISO- or HYPOINTENSE to normal gray matter
T1 Post-Contrast Mild, heterogeneous enhancement may occur 5-7 days after onset (represents blood-brain barrier breakdown in subacute phase)
Key Feature NO EXTRADURAL COMPRESSION - no disc material or mass compressing the spinal cord. Normal intervertebral disc spaces.

Clinical Presentation

Onset and History

  • Peracute onset (less than 6 hours) of neurological dysfunction
  • Often occurs during physical activity (running, jumping, playing)
  • Initial vocalization (yelp, scream, cry) at onset - suggests brief pain
  • Pain typically subsides quickly (within minutes to hours)
  • Neurological deficits are non-progressive after first 12-24 hours

Neurological Examination Findings

Key Clinical Features

  • Asymmetric/lateralized deficits (reported in 53-87% of cases) - one side more severely affected than the other
  • Absence of spinal hyperalgesia (pain on palpation) - a distinguishing feature from compressive IVDD
  • Deficits range from ataxia and paresis to complete plegia
  • Signs depend on spinal cord localization (see Neurolocalization section)

Neurolocalization in FCE

FCE can occur in any spinal cord segment. The most commonly affected regions in dogs with histologically confirmed FCE are C6-T2 (cervical intumescence) and L4-S3 (lumbosacral intumescence).

Feature FCE ANNPE IVDD (Hansen Type I)
Onset Peracute (during exercise) Peracute (during exercise) Acute to subacute
Pain Absent/brief at onset Often present initially (21-57%) Usually PRESENT (spinal hyperalgesia)
Lateralization Common (53-87%) Common (62-90%) Less common
Typical Breeds Large/giant, non-chondrodystrophic Non-chondrodystrophic Chondrodystrophic (Dachshund, Beagle, etc.)
MRI Findings Intramedullary T2 hyperintensity. No compression. Normal discs. Intramedullary T2 hyperintensity. Narrowed disc space. Epidural signal changes. EXTRADURAL COMPRESSION visible. Disc material in canal.
Location Any segment. C6-T2, L4-S3 common. T12-L2 most common T11-L2 (thoracolumbar); C2-C3 (cervical)
Treatment Conservative: supportive care, physical therapy Conservative: supportive care, physical therapy Often SURGICAL decompression

Diagnosis

Definitive diagnosis of FCE requires histopathological examination of affected spinal cord tissue demonstrating fibrocartilaginous material within spinal vessels. Antemortem diagnosis is presumptive and based on characteristic clinical presentation combined with MRI findings.

Magnetic Resonance Imaging (MRI) Findings

MRI is the imaging modality of choice and is essential for ruling out compressive lesions.

High-YieldMRI performed within 24-72 hours of onset may show NO intraparenchymal changes in some FCE cases. If clinical suspicion is high and initial MRI is unremarkable, repeat imaging after 72+ hours may reveal the lesion. Early use of diffusion-weighted imaging (DWI) may increase sensitivity for detecting acute ischemic injury.

Additional Diagnostic Findings

  • Spinal radiographs: Usually NORMAL (no disc calcification, no vertebral abnormalities)
  • CSF analysis: May be normal or show mild, nonspecific changes (mild elevation of protein, mild pleocytosis)
  • CBC/Chemistry: Typically normal; rule out underlying conditions that may predispose to embolism
Treatment Component Recommendations
Nursing Care Soft, padded bedding. Rotate recumbent patients every 4-6 hours to prevent pressure sores. Keep clean and dry.
Bladder Management Manual bladder expression 3-4 times daily if unable to urinate independently. Monitor for UTI. Consider indwelling catheter if needed.
Physical Rehabilitation Passive range of motion exercises. Massage therapy. Neuromuscular electrical stimulation. Hydrotherapy (underwater treadmill). Assisted walking with slings/harnesses.
Pain Management Only if spinal hyperalgesia present (uncommon). NSAIDs or opioids as needed. Avoid corticosteroids (no proven benefit, potential harm).
Mobility Aids Harnesses with handles (e.g., Help 'Em Up Harness). Slings for support. Walking carts for non-ambulatory patients.

Differential Diagnosis

Differentiation between FCE and other acute non-compressive myelopathies can be challenging. Key differentials include:

ANNPE = Acute Non-Compressive Nucleus Pulposus Extrusion. In ANNPE, hydrated nucleus pulposus extrudes through a tear in the annulus fibrosus, contuses the spinal cord, and dissipates without causing ongoing compression.

NAVLE TipThe key differentiating feature on MRI between FCE and ANNPE is that ANNPE often shows a narrowed intervertebral disc space with signal changes in the epidural space dorsal to the affected disc. FCE typically shows NO changes to the intervertebral discs. However, both are NON-COMPRESSIVE.
Positive Prognostic Indicators Negative Prognostic Indicators
Preserved deep pain perception (nociception) Loss of deep pain perception
Ambulatory or non-ambulatory paresis (can move limbs) Complete plegia (paralysis)
Early improvement (within first 7-14 days) No improvement within 14 days
Smaller extent of MRI lesion Extensive MRI lesion (T2 hyperintensity greater than 2x vertebral body length)
Early initiation of physical rehabilitation Involvement of an intumescence (C6-T2 or L4-S3) with LMN signs

Treatment

There is no specific medical treatment for FCE. Management is conservative and focuses on supportive care and physical rehabilitation. No medications, including corticosteroids or vasodilators, have been proven to speed recovery.

Supportive Care Components

High-YieldPhysical therapy is the ONLY intervention proven to speed recovery from FCE. Encourage early mobilization as soon as the patient is stable. Avoid strict cage rest - appropriate activity promotes recovery.

Prognosis and Prognostic Factors

The overall prognosis for FCE is fair to good. Approximately 84% of dogs with FCE have a successful outcome and return to a good quality of life. FCE is unlikely to recur.

Prognostic Factors

Recovery Timeline

  • Voluntary motor activity recovery: Median 6 days (range 2.5-15 days)
  • Unassisted ambulation: Median 11 days (range 4-136 days)
  • Maximum recovery: Typically reached within 3-4 months
  • Most significant improvement occurs in the first 3-7 days
NAVLE TipLoss of deep pain perception is the SINGLE MOST IMPORTANT negative prognostic indicator. Dogs with FCE and absent deep pain rarely recover to functional status. If no improvement is seen within 14 days and the dog remains paralyzed without deep pain, the prognosis is grave and euthanasia should be discussed.

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →